Sensitivity and Specificity of Leucocytes Subpopulation Versus Platelet Indices in Prediction of Clinical Outcome for Candidates With Sepsis. A Bi-centric Observational Clinical Trial
NCT ID: NCT06612307
Last Updated: 2024-09-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
161 participants
OBSERVATIONAL
2024-09-25
2025-08-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Platelets to Lymphocytes Ratio in Sepsis
NCT05399225
Platelet Reactivity in Septic Shock
NCT03716310
Study on the Establishment of a System for Early Warning and Prognostic Evaluation of Patients With Sepsis
NCT05229328
Comparison Between the Progostic Value of the Procalcitonin and the Platelet/Total Leukocytic Count Ratio in Sepsis
NCT06991686
Evaluation of the Prognostic Value of Immature Platelet Fraction
NCT07039227
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* History of surgery in the last 7 days from admission.
* Immunocompromised population ( post-transplantation, steroid use \> 5 mg per day, malignancy, HIV, on chemotherapy).
* Population with history of thrombocytopenia ( ITP, aplastic anemia, drug induced)
* History of thrombocytosis ( idiopathic thrombocytosis, post-splenectomy)
* History of platelet transfusion one week before admission.
* Bone marrow transplanted population .
* Chronic liver and kidney disease.
* Von-Willebrand disease.
* Patients on antiplatelet therapy ( Aspirin, clopidogrel).
* Thrombocytopenic population ( ITP, TTP,HELLP) .
* Myelodysplastic or proliferative patients.
* Blood dyscarsiasis
* Obestetric parturients.
20 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Minia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mina Maher
Ass professor anesthesia and pain
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Anet 19-2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.